Novartis AG
(NYSE : NVS)

( )
NVS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 0.21%34.100.9%$1166.03m
JNJJohnson & Johnson 0.20%143.100.7%$1086.76m
BMYBristol-Myers Squibb Co. 0.00%60.301.0%$985.23m
MRKMerck & Co., Inc. 0.10%78.780.7%$831.79m
ABBVAbbVie, Inc. -0.42%99.001.9%$784.99m
LLYEli Lilly & Co. -0.09%166.741.1%$696.31m
VXRTVaxart, Inc. 4.28%9.250.0%$312.87m
AZNAstraZeneca Plc 1.09%54.061.2%$298.39m
RPRXRoyalty Pharma Plc 2.04%47.050.1%$233.45m
NVSNovartis AG 0.02%87.820.2%$155.54m
GSKGlaxoSmithKline Plc 1.02%40.780.2%$118.58m
RGENRepligen Corp. -1.94%124.147.1%$117.72m
NVONovo Nordisk A/S 0.58%65.440.1%$95.02m
RETAReata Pharmaceuticals, Inc. -2.99%155.643.4%$81.74m
SNYSanofi 0.66%51.770.2%$74.29m

Company Profile

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.